C4 Therapeutics, Inc.
COMPOUNDS FOR TARGETED DEGRADATION OF BRD9
Last updated:
Abstract:
BRD9 protein degradation compounds or pharmaceutically acceptable salts thereof are provided for the treatment of disorders mediated by BRD9, including but not limited to abnormal cellular proliferation.
Status:
Application
Type:
Utility
Filling date:
2 Dec 2021
Issue date:
31 Mar 2022